BioNxt Solutions (OTCMKTS:BNXTF) Trading Down 8.3% – Time to Sell?

Shares of BioNxt Solutions Inc. (OTCMKTS:BNXTFGet Free Report) fell 8.3% on Thursday . The company traded as low as $0.3031 and last traded at $0.3570. 11,615 shares were traded during trading, an increase of 922% from the average session volume of 1,137 shares. The stock had previously closed at $0.3895.

BioNxt Solutions Price Performance

The business has a 50-day moving average of $0.41 and a two-hundred day moving average of $0.46. The company has a market cap of $43.73 million, a P/E ratio of -8.93 and a beta of 0.87.

BioNxt Solutions Company Profile

(Get Free Report)

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.

Read More

Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.